University of Birmingham's cancer immunotherapy developer Revitope Oncology secured equity funding as part of a $160m alliance with Junshi Biosciences.
UCLA has been named as the first university partner of an academic collaboration bridge backed by Evotec, Samsara BioCapital and KCK.
Taiho Ventures has supplied a $10m extension for Caltech spinout Axial Biotherapeutics’ series B, bringing the total to $35m.
University of Calgary-born Parvus Therapeutics has inked an $800m deal with Genentech to develop and commercialise treatments for autoimmune diseases.
UC Riverside has sealed an MOU with incubator Murrieta Genomics to drive its genomics research and build links between the innovation ecosystems of both parties.
The industry-academia partnership will start out with collaborations in the healthcare, robotics and human resources spaces, including a sports science tie-up with a Rakuten-owned baseball team and plans for software development hackathons.
University of Dundee intelligent drug design spinout Exscientia has struck a business deal with Celgene after raising series B funding from the corporate in January.
Hebrew University Jerusalem’s Yissum is tuning up an extension of its overseas commercialisation activities in the US, South America and China.